In respect to the association of cyclin D1 expression level with the clinico-pathological features of BC, our findings showed that the overexpression of cyclin D1 was associated with IDC, high staging, high grading, lymph node metastasis, and finally hormonal status except HER2-neu status. Here, ERBB2 is linked to breast cancer.